Concepedia

Publication | Open Access

Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes

DOIFull Paper Access

37

Citations

1

References

2018

Year

Grit Andersen, Grégory Meiffren, Daniela Lamers, J. Hans DeVries, Aymeric Ranson, Cyril Seroussi, Bertrand Alluis, Martin Gaudier, Olivier Soula, Tim Heise
Diabetes Obesity and Metabolism

Abstract

BCLIS was well tolerated and safe over 14 days of treatment and significantly improved postprandial BG vs LIS when administered at mealtime.

References

YearCitations

Page 1